Detalhe da pesquisa
1.
TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signaling.
Proc Natl Acad Sci U S A
; 116(1): 211-216, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559202
2.
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Gut
; 68(8): 1396-1405, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30448772
3.
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.
Blood
; 128(2): 253-64, 2016 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27257182
4.
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
J Exp Med
; 203(13): 2817-27, 2006 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145956
5.
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.
J Clin Immunol
; 32(3): 632-46, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318393
6.
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.
Open Res Eur
; 1: 107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967081
7.
Mutant mouse models of oxidative stress.
Transgenic Res
; 19(2): 155-64, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19662508
8.
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.
Cancer Res
; 77(23): 6627-6640, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972073
9.
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.
Oncoimmunology
; 5(10): e1146843, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27853633
10.
The thymus-specific serine protease TSSP/PRSS16 is crucial for the antitumoral role of CD4(+) T cells.
Cell Rep
; 10(1): 39-46, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25543139
11.
Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.
EMBO Mol Med
; 7(6): 802-18, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25828351
12.
Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL.
Oncotarget
; 5(10): 3168-72, 2014 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24930440
13.
Saccharomyces boulardii improves intestinal cell restitution through activation of the α2ß1 integrin collagen receptor.
PLoS One
; 6(3): e18427, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21483797
14.
Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis.
Antioxid Redox Signal
; 15(6): 1639-53, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21235351
15.
Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Inflamm Bowel Dis
; 16(1): 96-104, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19572375
16.
Distinct thresholds govern Myc's biological output in vivo.
Cancer Cell
; 14(6): 447-57, 2008 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19061836
17.
LAT regulates gammadelta T cell homeostasis and differentiation.
Nat Immunol
; 4(10): 999-1008, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12970761